Northwest Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Northwest Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-149	Closed	-$3.09K	–	359
2025 Q1	$3.09K	Hold	149	–	–	﹤0.01%	376
2024 Q4	$3.51K	Hold	149	–	–	﹤0.01%	363
2024 Q3	$3.81K	Hold	149	–	–	﹤0.01%	380
2024 Q2	$3.5K	Hold	149	–	–	﹤0.01%	373
2024 Q1	$4.29K	Hold	149	–	–	﹤0.01%	444
2023 Q4	$4.89K	Hold	149	–	–	﹤0.01%	434
2023 Q3	$4.15K	Hold	149	–	–	﹤0.01%	434
2023 Q2	$5.08K	Buy	+149	New	+$4.68K	﹤0.01%	430

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northwest Capital Management's ARKG Position: Q2 2025 in Review

Northwest Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 149 shares — an estimated $3.09K sold.

Northwest Capital Management first reported a position in ARKG in Q2 2023 and held it in 8 quarters. The position peaked at $5.08K in Q2 2023. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

Northwest Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
Northwest Capital Management sold 149 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $3.09K.
Northwest Capital Management first reported a position in ARK Genomic Revolution ETF in Q2 2023 and held it in 8 quarters.
Northwest Capital Management's ARK Genomic Revolution ETF position peaked at $5.08K in Q2 2023.
213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Northwest Capital Management's 13F filing for Q2 2025, filed 25 Jul 2025.